Ritivixibat
Ritivixibat is an ileal bile acid transporter (IBAT) inhibitor that modulates bile acid enterohepatic circulation. It is a research tool for investigating metabolic and hepatic disorders, including cholestatic liver diseases, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2460667-52-9
Field of Research
Pharmacology & Drug Discovery
Smiles
C (CCC) C1 (CCCC) CN (C=2C (S (=O) (=O) N1) =CC (OCCC (O) =O) =C (SC) C2) C3=CC=CC=C3
Molecular Formula
C26H36N2O5S2
Molecular Weight
520.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1084655-01 0.02 mg (E-Coli)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details MBS1084655-02 0.1 mg (E-Coli)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details MBS1084655-03 0.02 mg (Yeast)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details MBS1084655-04 0.1 mg (Yeast)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details MBS1084655-05 0.02 mg (Baculovirus)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details MBS1084655-06 1 mg (E-Coli)
Recombinant Laticauda semifasciata Long neurotoxin Ls3
Sign In for Pricing
View Details